← The Wire
KYMRNasdaq
Kymera Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1815442
Kymera Therapeutics develops oral medicines using targeted protein degradation to eliminate disease-causing proteins
red 8-K · 90d⚡ Elevated coverage
$7.09B
Market cap
$109.32
Last close
+1.1%
1D
+9.9%
5D
1.7M
Volume
Price · last 39 sessions+30.8%
May 4L $71.29 · H $116.46Jun 29
138
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
SC 13D/ASC 13D/AJun 26, 20268-KReg FD Disclosure · Company UpdateJun 25, 20268-KShareholder VoteJun 24, 20268-KExecutive ChangeJun 8, 202610-Q10-QApr 30, 20268-KResults of OperationsApr 30, 2026DEFA14ADEFA14AApr 29, 2026DEF 14ADEF 14AApr 29, 20268-KBylaw AmendmentMar 27, 20268-KMaterial Agreement · Agreement TerminatedFeb 26, 2026424B5424B5Feb 26, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KResults of Operations · Reg FD DisclosureJan 13, 2026SC 13D/ASC 13D/ADec 15, 2025SC 13D/ASC 13D/ADec 11, 20258-KMaterial Agreement · Company UpdateDec 10, 2025424B5424B5Dec 10, 2025424B5424B5Dec 8, 20258-KReg FD DisclosureDec 8, 20258-KReg FD Disclosure · Company UpdateDec 8, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 20258-KExecutive Change · Reg FD DisclosureSep 3, 202510-Q10-QAug 11, 20258-KResults of OperationsAug 11, 20258-KMaterial Agreement · Company UpdateJun 27, 20258-KShareholder VoteJun 27, 2025424B5424B5Jun 27, 2025424B5424B5Jun 25, 20258-KReg FD Disclosure · Company UpdateJun 25, 20258-KReg FD Disclosure · Company UpdateJun 25, 20258-KReg FD DisclosureJun 2, 20258-KReg FD Disclosure · Company UpdateJun 2, 202510-Q10-QMay 9, 20258-KResults of Operations · Reg FD DisclosureMay 9, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KExecutive ChangeMar 3, 202510-K10-KFeb 27, 20258-KExecutive Change · Results of OperationsFeb 27, 20258-KResults of Operations · Reg FD DisclosureJan 14, 2025SC 13GSC 13GNov 12, 202410-Q10-QOct 31, 20248-KResults of OperationsOct 31, 20248-KMaterial Agreement · Company UpdateAug 20, 2024424B5424B5Aug 20, 2024424B5424B5Aug 19, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KReg FD Disclosure · Company UpdateJul 8, 20248-KExecutive Change · Shareholder VoteJun 20, 202410-Q10-QMay 2, 20248-KResults of OperationsMay 2, 2024DEFA14ADEFA14AApr 24, 2024DEF 14ADEF 14AApr 24, 2024SC 13DSC 13DApr 1, 20248-KExecutive ChangeApr 1, 202410-K10-KFeb 22, 20248-KResults of OperationsFeb 22, 20248-KMaterial Agreement · Results of OperationsJan 5, 2024424B5424B5Jan 5, 2024424B5424B5Jan 4, 20248-KReg FD DisclosureJan 4, 20248-KReg FD Disclosure · Company UpdateJan 4, 20248-KReg FD Disclosure · Company UpdateNov 2, 202310-Q10-QNov 2, 20238-KResults of OperationsNov 2, 202310-Q10-QAug 3, 20238-KResults of OperationsAug 3, 20238-KShareholder VoteJun 16, 20238-KExecutive Change · Reg FD DisclosureMay 22, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 20238-KReg FD DisclosureMar 10, 20238-KExecutive ChangeFeb 27, 202310-K10-KFeb 23, 20238-KResults of OperationsFeb 23, 2023
Insider Activity
In the 90 days to Mar 25, 2026: 6 sold $26.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 24,727 | $80.26 | $2.0M |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 52,975 | $77.21 | $4.1M |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 22,756 | $76.73 | $1.7M |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 8,214 | $78.40 | $644K |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 6,105 | $79.87 | $488K |
| Mar 23, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 1,200 | $80.05 | $96K |
| Mar 20, 2026 | Esposito PamelaDirector | Sell | 1,200 | $79.94 | $96K |
| Mar 20, 2026 | Esposito PamelaDirector | Sell | 700 | $77.71 | $54K |
| Mar 20, 2026 | Esposito PamelaDirector | Sell | 600 | $79.24 | $48K |
| Mar 11, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 12,882 | $83.10 | $1.1M |
| Mar 11, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 11,111 | $83.72 | $930K |
| Mar 11, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 1,765 | $82.13 | $145K |
| Mar 4, 2026 | Gollob JaredChief Medical Officer | Sell | 2,519 | $85.04 | $214K |
| Mar 4, 2026 | Jacobs Bruce N.Chief Financial Officer | Sell | 2,519 | $85.04 | $214K |
| Mar 4, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 2,017 | $85.04 | $172K |
| Mar 4, 2026 | Gollob JaredChief Medical Officer | Sell | 1,437 | $85.78 | $123K |
| Mar 4, 2026 | Jacobs Bruce N.Chief Financial Officer | Sell | 1,437 | $85.78 | $123K |
| Mar 4, 2026 | Chadwick Jeremy GChief Operating Officer | Sell | 1,150 | $85.78 | $99K |
| Mar 4, 2026 | Gollob JaredChief Medical Officer | Sell | 492 | $84.00 | $41K |
| Mar 4, 2026 | Jacobs Bruce N.Chief Financial Officer | Sell | 492 | $84.00 | $41K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 2 reputable articles · skews ▲ positive.
Investor's Business DailyIs Kymera Therapeutics The Next Big Rival To Regeneron And Sanofi?4d agoCNBCStocks making the biggest moves midday: BlackBerry, Kymera Therapeutics, Apple, Wendy's & more4d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance